InsidersTradesSigma
Browse the detailed record of transactions filed by Sperzel John J III, Chief Executive Officer. Insider active across 1 company, notably T2 Biosystems, Inc.. Aggregated, 2 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €14k. Activity tracked since 7 April 2022. The latest transaction was filed on 7 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
John J. Sperzel III is the Chairman, CEO, and President of T2 Biosystems, Inc. He is responsible for the strategic direction of the company, overseeing product development and operations. With a strong background in the biopharmaceutical sector, Sperzel is committed to advancing therapeutic innovations and improving patient outcomes.